CRP and rheumatoid arthritis: Other studies have shown that supplementation with high doses of polyunsaturated fatty acids (PUFAs) reduces ESR, CRP, and IL-1B levels while improving Disease Activity Score-28 (DAS-28) scores and quality of life measures in patients with RA [5,6].